NCT07006077 2026-02-27
Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer
Hangzhou Converd Co., Ltd.
Phase 2 Recruiting
Clinical Trials
4 trialsNCT06463665 2025-09-26
VIRO-25
Genelux Corporation
Phase 2 Recruiting
NCT01171651 2016-01-20
A Study of Recombinant Vaccinia Virus Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma
SillaJen, Inc.
Phase 2 Completed
NCT01387555 2015-03-11
TRAVERSE
Jennerex Biotherapeutics
Phase 2 Completed